Search results - 5 results

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.

Synthetic Vaccines, Virus-Like Particle Veterinary Medicine Viral Matrix Proteins Abstract: Virus-like particles (VLP s) are promising molecular structures for the design and construction of novel vaccines, ...

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.

Virus-Like Particle Viral Load Abstract: The ectodomain of influenza A matrix protein 2 (M2 e) is a candidate for a universal influenza A vaccine. We used recombinant Hepatitis B core antigen to produce ...

Evaluation of two different swab transport systems in the detection of avian influenza virus excretion from infected Pekin ducks (Anas platyrhynchos).

184, Issue 1-2, p.8-14 (2012) Keywords: Animals Cloaca Ducks Influenza A virus Influenza in Birds Oropharynx RNA, Viral Sensitivity and Specificity specimen handling Viral Matrix Proteins Abstract: The ...

Antiserum against the conserved nine amino acid N-terminal peptide of influenza A virus matrix protein 2 is not immunoprotective.

A virus Influenza Vaccines mice Mice, Inbred BALB C Orthomyxoviridae Infections Rabbits Viral Matrix Proteins Abstract: The recent emergence and rapid spread of the pandemic H1N1 swine influenza virus ...

Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

Sensitivity and Specificity Viral Matrix Proteins Abstract: Vaccination programs for the control of avian influenza (AI) in birds have restrictions because of some limited efficacy and the difficulty of ...

QR code

QR code for this page URL